ADOIF
Price:
$8.871
Market Cap:
$83.76M
Adocia S.A., a biotechnology firm founded in Lyon, France, in 2005, operates at the clinical stage, focusing its research and development efforts on optimizing existing therapeutic proteins and peptides for the management of diabetes and various other metabolic conditions. The company's core innovation lies in its proprietary BioChaperone technological platform, specifically engineered to enhance the effectiveness and performance of therapeutic proteins. Adocia's product pipeline currently in clinical trials features several advanced insulin formulations. These include BioChaperone Lispro U100 and U200, which offer ultra-rapid action derived from rapid insulin lispro. Other notable candidate...[Read more]
Industry
Biotechnology
IPO Date
2014-04-04
Stock Exchange
OTC
Ticker
ADOIF
According to Adocia S.A.’s latest financial reports and current stock price. The company's current ROE is -3796.57%. This represents a change of -1414.98% compared to the average of 288.72% of the last 4 quarters.
The mean historical ROE of Adocia S.A. over the last ten years is -74.67%. The current -3796.57% ROE has changed 4.98% with respect to the historical average. Over the past ten years (40 quarters), ADOIF's ROE was at its highest in in the June 2025 quarter at 1.51%. The ROE was at its lowest in in the December 2014 quarter at -605.59%.
Average
-74.67%
Median
-0.92%
Minimum
-1112.74%
Maximum
306.07%
Discovering the peaks and valleys of Adocia S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 475.20%
Maximum Annual ROE = 306.07%
Minimum Annual Increase = -499.45%
Minimum Annual ROE = -1112.74%
| Year | ROE | Change |
|---|---|---|
| 2025 | -1112.74% | -468.88% |
| 2024 | 301.65% | -1.45% |
| 2023 | 306.07% | 475.20% |
| 2022 | 53.21% | -67.69% |
| 2021 | 164.71% | -144.73% |
| 2020 | -368.23% | 455.03% |
| 2019 | -66.34% | -499.45% |
| 2018 | 16.61% | -171.59% |
| 2017 | -23.20% | 25.71% |
| 2016 | -18.46% | -169.18% |
The current ROE of Adocia S.A. (ADOIF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-168.34%
5-year avg
-57.42%
10-year avg
-74.67%
Adocia S.A.’s ROE is greater than Eupraxia Pharmaceuticals Inc. (-50.81%), greater than Entasis Therapeutics Holdings Inc. (-112.91%), less than Jounce Therapeutics, Inc. (-25.03%), less than Opiant Pharmaceuticals, Inc. (7.31%), less than Cyteir Therapeutics, Inc. (-26.35%), greater than Miromatrix Medical Inc. (-74.80%), less than HilleVax, Inc. (-29.97%), greater than Decibel Therapeutics, Inc. (-56.38%), greater than aTyr Pharma, Inc. (-99.87%), less than Paratek Pharmaceuticals, Inc. (42.54%),
| Company | ROE | Market cap |
|---|---|---|
| -50.81% | $108.29M | |
| -112.91% | $0 | |
| -25.03% | $98.95M | |
| 7.31% | $108.80M | |
| -26.35% | $108.71M | |
| -74.80% | $92.95M | |
| -29.97% | $104.76M | |
| -56.38% | $123.37M | |
| -99.87% | $43.18M | |
| 42.54% | $127.83M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adocia S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Adocia S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Adocia S.A.'s ROE?
How is the ROE calculated for Adocia S.A. (ADOIF)?
What is the highest ROE for Adocia S.A. (ADOIF)?
What is the 3-year average ROE for Adocia S.A. (ADOIF)?
What is the 5-year average ROE for Adocia S.A. (ADOIF)?
How does the current ROE for Adocia S.A. (ADOIF) compare to its historical average?